Siponimod Improves MRI Outcomes in Patients With Secondary Progressive MSNovember 22, 2017Multiple Sclerosis
Durable Improvements in Clinical Outcomes With Alemtuzumab: Seven-Year Follow-UpNovember 2, 2017Multiple Sclerosis
Oligoclonal Bands Could Be a Valuable Criterion for the Diagnosis of MSOctober 25, 2017Multiple Sclerosis
The Diagnostic Value of 2010 McDonald Criteria Versus 2016 MAGNIMS Guidelines for Special MS PopulationsOctober 25, 2017Multiple Sclerosis
